Restricted accessResearch articleFirst published online 2016-02
Pseudotyping Serotype 5 Adenovirus with the Fiber from Other Serotypes Uncovers a Key Role of the Fiber Protein in Adenovirus 5-Induced Thrombocytopenia
Adenovirus (Ad) infection in humans is associated with inflammatory responses and thrombocytopenia. Although several studies were conducted in mice models to understand molecular and cellular mechanisms of Ad-induced inflammatory responses, only few of them turned their interest toward the mechanisms of Ad-induced thrombocytopenia. Using different depletion methods, the present study ruled out any significant role of spleen, macrophages, and vitamin K-dependent factor in Ad-induced thrombocytopenia. Interestingly, mice displaying thrombocytopenia expressed high levels of cytokines/chemokines after Ad administration. Most importantly, pseudotyping adenovirus with the fiber protein from other serotypes was associated with reduction of both cytokine/chemokine production and thrombocytopenia. Altogether, our results suggest that capsid fiber protein (and more precisely its shaft) of Ad serotype 5 triggers the cytokine production that leads to Ad-induced thrombocytopenia.
Get full access to this article
View all access options for this article.
References
1.
BergelsonJM, CunninghamJA, DroguettG, et al.Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, 1997; 275:1320–1323.
2.
WickhamTJ, MathiasP, ChereshDA, et al.Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell, 1993; 73:309–319.
3.
HofherrSE, MokH, GushikenFC, et al.Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum Gene Ther, 2007; 18:837–848.
4.
LozierJN, MetzgerME, DonahueRE, et al.Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity. Blood, 1999; 94:3968–3975.
5.
ParkerAL, WaddingtonSN, NicolCG, et al.Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood, 2006; 108:2554–2561.
6.
BakerAH, McVeyJH, WaddingtonSN, et al.The influence of blood on in vivo adenovirus bio-distribution and transduction. Mol Ther, 2007; 15:1410–1416.
VigantF, DescampsD, JullienneB, et al.Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver. Mol Ther, 2008; 16:1474–1480.
9.
VigneE, DedieuJF, BrieA, et al.Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation. Gene Ther, 2003; 10:153–162.
10.
AlbaR, BradshawAC, ParkerAL, et al.Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: Effect of mutagenesis on FX interactions and gene transfer. Blood, 2009; 114:965–971.
11.
WaddingtonSN, ParkerAL, HavengaM, et al.Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: Fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. J Virol, 2007; 81:9568–9571.
12.
ShortJJ, RiveraAA, WuH, et al.Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Mol Cancer Ther, 2010; 9:2536–2544.
13.
CichonG, Boeckh-HerwigS, KueminD, et al.Titer determination of Ad5 in blood: A cautionary note. Gene Ther, 2003; 10:1012–1017.
14.
HigginbothamJN, SethP, BlaeseRM, et al.The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. Hum Gene Ther, 2002; 13:129–141.
15.
CotterMJ, ZaissAK, MuruveDA. Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J Virol, 2005; 79:14622–14631.
16.
LoreK, AdamsWC, HavengaMJ, et al.Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses. J Immunol, 2007; 179:1721–1729.
17.
StoneD, LiuY, ShayakhmetovD, et al.Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J Virol, 2007; 81:4866–4871.
18.
WolinsN, LozierJ, EggermanTL, et al.Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance. Br J Haematol, 2003; 123:903–905.
19.
SungMW, YehHC, ThungSN, et al.Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: Results of a phase I clinical trial. Mol Ther, 2001; 4:182–191.
20.
RaperSE, YudkoffM, ChirmuleN, et al.A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther, 2002; 13:163–175.
21.
LiJL, LiuHL, ZhangXR, et al.A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients. Gene Ther, 2009; 16:376–382.
22.
ShimonyN, ElkinG, Kolodkin-GalD, et al.Analysis of adenoviral attachment to human platelets. Virol J, 2009; 6:25.
23.
EggermanTL, MondoroTH, LozierJN, et al.Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation. Hum Gene Ther, 2002; 13:125–128.
24.
GupaloE, BuriachkovskaiaL, OthmanM. Human platelets express CAR with localization at the sites of intercellular interaction. Virol J, 2011; 8:456.
25.
GupaloE, KukC, QaduraM, et al.Platelet-adenovirus vs. inert particles interaction: Effect on aggregation and the role of platelet membrane receptors. Platelets, 2013; 24:383–391.
26.
OthmanM, LabelleA, MazzettiI, et al.Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood, 2007; 109:2832–2839.
27.
AppledornDM, McBrideA, SereginS, et al.Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther, 2008; 15:1606–1617.
28.
ManeVP, ToiettaG, McCormackWM, et al.Modulation of TNFalpha, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors. Gene Ther, 2006; 13:1272–1280.
29.
SirenaD, RuzsicsZ, SchaffnerW, et al.The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology, 2005; 343:283–298.
30.
LecollinetS, GavardF, HavengaMJ, et al.Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers. J Virol, 2006; 80:2747–2759.
31.
MartinK, BrieA, SaulnierP, et al.Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol Ther, 2003; 8:485–494.
32.
ManickanE, SmithJS, TianJ, et al.Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther, 2006; 13:108–117.
33.
CichonG, SchmidtHH, BenhidjebT, et al.Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med, 1999; 1:360–371.
34.
MorralN, O'NealWK, RiceK, et al.Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther, 2002; 13:143–154.
WadenvikH, KuttiJ. The spleen and pooling of blood cells. Eur J Haematol, 1988; 41:1–5.
37.
AsterRH. Studies of the fate of platelets in rats and man. Blood, 1969; 34:117–128.
38.
PesonenS, NokisalmiP, EscutenaireS, et al.Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors. Gene Ther, 2010; 17:892–904.
39.
CoughlanL, VallathS, GrosA, et al.Combined fiber modifications both to target alpha(v)beta(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5. Hum Gene Ther, 2012; 23:960–979.
40.
WongCH, JenneCN, PetriB, et al.Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol, 2013; 14:785–792.
41.
XuZ, TianJ, SmithJS, et al.Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol, 2008; 82:11705–11713.
42.
van RooijenN, BakkerJ, SandersA. Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol, 1997; 15:178–185.
43.
De GeestB, SnoeysJ, Van LinthoutS, et al.Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone. Hum Gene Ther, 2005; 16:1439–1451.
44.
SereginSS, AppledornDM, McBrideAJ, et al.Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy. Mol Ther, 2009; 17:685–696.
45.
NiS, GaggarA, Di PaoloN, et al.Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting. Cancer Gene Ther, 2006; 13:1072–1081.
46.
DescampsD, BenihoudK. Two key challenges for effective adenovirus-mediated liver gene therapy: Innate immune responses and hepatocyte-specific transduction. Curr Gene Ther, 2009; 9:115–127.
47.
BenihoudK, SaloneB, EsselinS, et al.The role of IL-6 in the inflammatory and humoral response to adenoviral vectors. J Gene Med, 2000; 2:194–203.
48.
KiangA, HartmanZC, EverettRS, et al.Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol Ther, 2006; 14:588–598.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
